Endothelial progenitor/stem cells in engineered vessels for vascular transplantation

被引:0
|
作者
Durai Murugan Muniswami
L. Vinod Kumar Reddy
Soosai Manickam Amirtham
Sandhya Babu
Arunai Nambi Raj
Dwaipayan Sen
Geetha Manivasagam
机构
[1] Centre for Biomaterials,Department of Physiology
[2] Cellular & Molecular Theranostics (CBCMT),undefined
[3] VIT,undefined
[4] Department of Microbiology,undefined
[5] Karpagam Academy of Higher Education (Deemed to be University),undefined
[6] Christian Medical College,undefined
[7] Sandhya Hospital,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Background: Dysfunction of blood vessel leads to aneurysms, myocardial infarction and other thrombosis conditions. Current treatment strategies are transplantation of blood vessels from one part of the body to other dysfunction area, or allogenic, synthetic. Due to shortage of the donor, painful dissection, and lack of efficacy in synthetic, there is a need for alternative to native blood vessels for transplantation. Methods: Human umbilical-cord tissue obtained from the hospital with the informed consent. Umbilical-cord blood vessels were isolated for decellularization and to establish endothelial cell culture. Cultured cells were characterized by immunophenotype, gene expression and in vitro angiogenesis assay. Decellularized blood vessels were recellularized with the endothelial progenitors and Wharton jelly, CL MSCs (1:1), which was characterized by MTT, biomechanical testing, DNA content, SEM and histologically. Bioengineered vessels were transplanted into the animal models to evaluate their effect. Results: Cultured cells express CD31 and CD14 determining endothelial progenitor cells (EPCs). EPCs expresses various factors such as angiopoitin1, VWF, RANTES, VEGF, BDNF, FGF1, FGF2, HGF, IGF, GDNF, NGF, PLGF, NT3, but fail to express NT4, EGF, and CNTF. Pro and anti-inflammatory cytokine expressions were noticed. Functionally, these EPCs elicit in vitro tube formation. Negligible DNA content and intact ECM confirms the efficient decellularization of tissue. The increased MTT activity in recellularized tissue determines proliferating cells and biocompatibility of the scaffolds. Moreover, significant (P < 0.05) increase in maximum force and tensile of recellularized biomaterial as compared to the decellularized scaffolds. Integration of graft with host tissue, suggesting biocompatible therapeutic biomaterial with cells. Conclusion: EPCs with stem cells in engineered blood vessels could be therapeutically applicable in vascular surgery.
引用
收藏
相关论文
共 50 条
  • [1] Endothelial progenitor/stem cells in engineered vessels for vascular transplantation
    Muniswami, Durai Murugan
    Reddy, L. Vinod Kumar
    Amirtham, Soosai Manickam
    Babu, Sandhya
    Raj, Arunai Nambi
    Sen, Dwaipayan
    Manivasagam, Geetha
    JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2020, 31 (12)
  • [2] Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells
    Liu, Qi
    Xi, Yutao
    Terry, Toya
    So, Shui-Ping
    Mohite, Anita
    Zhang, Jia
    Wu, Geru
    Liu, Xiaobing
    Cheng, Jie
    Ruan, Ke-He
    Willerson, James T.
    Dixon, Richard A. F.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (07) : 2907 - 2916
  • [3] Pitavastatin nanoparticle-engineered endothelial progenitor cells repair injured vessels
    Huanyun Liu
    Pang Bao
    Lufeng Li
    Yuqing Wang
    Chunxin Xu
    Mengyang Deng
    Jihang Zhang
    Xiaohui Zhao
    Scientific Reports, 7
  • [4] Pitavastatin nanoparticle-engineered endothelial progenitor cells repair injured vessels
    Liu, Huanyun
    Bao, Pang
    Li, Lufeng
    Wang, Yuqing
    Xu, Chunxin
    Deng, Mengyang
    Zhang, Jihang
    Zhao, Xiaohui
    SCIENTIFIC REPORTS, 2017, 7
  • [5] Endothelial progenitor cells for fabrication of engineered vascular units and angiogenesis induction
    Rashidi, Somayyeh
    Bagherpour, Ghasem
    Abbasi-Malati, Zahra
    Khosrowshahi, Nafiseh Didar
    Chegeni, Sara Aghakhani
    Roozbahani, Golbarg
    Lotfimehr, Hamid
    Sokullu, Emel
    Rahbarghazi, Reza
    CELL PROLIFERATION, 2024, 57 (09)
  • [6] Potential of baboon endothelial progenitor cells for tissue engineered vascular grafts
    Hinds, Monica T.
    Ma, MinHui
    Tran, Noi
    Ensley, Ann E.
    Lakis, Stephanie M. Kla
    Vartanian, Keri B.
    Markway, Brandon D.
    Nerern, Robert M.
    Son, Stephen R. Har
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2008, 86A (03) : 804 - 812
  • [7] Endothelial progenitor cells: The promise of vascular stem cells for plastic surgery
    Tepper, OM
    Galiano, RD
    Kalka, C
    Gurtner, GC
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 111 (02) : 846 - 854
  • [8] Endothelial progenitor cells demonstrate promise for tissue-engineered vascular grafts
    Dong, Y.
    Jesse, A. M.
    Kohn, A.
    REGENERATIVE MEDICINE, 2010, 5 (03) : 320 - 320
  • [9] Vascular diseases await translation of blood vessels engineered from stem cells
    Samuel, Rekha
    Duda, Dan G.
    Fukumura, Dai
    Jain, Rakesh K.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (309)
  • [10] Human endothelial stem/progenitor cells, angiogenic factors and vascular repair
    Watt, Suzanne M.
    Athanassopoulos, Athanasios
    Harris, Adrian L.
    Tsaknakis, Grigorios
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2010, 7 : S731 - S751